Daneng Li, M.D., a City of Hope associate professor in the Department of Medical Oncology & Therapeutics Research commented:
“The results show that our novel oncolytic virus — both alone or in combination with immunotherapy — has the ability to control various cancer types previously resistant to other treatment options, and these early results provide patients with hope of a new treatment option for cancers refractory to standard treatment.”
GLTAH
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.045(12.3%) |
Mkt cap ! $70.31M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 31.5¢ | $1.393M | 4.175M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 233415 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 29252 | 1 |
View Market Depth
| Last trade - 15.54pm 22/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |